Should I buy into a hyped IPO like SpaceX?

What's actually happening

SpaceX listed on the Nasdaq in June 2026 at $135 a share — a $1.75 trillion valuation, the largest IPO ever. The company lost $4.9 billion in 2025 on $18.7 billion of revenue. Demand was roughly twice oversubscribed, with an unusually large ~30% of shares allocated directly to retail investors. OpenAI and Anthropic — both also unprofitable — are expected to follow later in 2026.

Behind the scenes, something quieter happened. Index funds don't buy at the IPO — a fund owns what's in the index, and a new listing isn't in one on day one. This spring, SpaceX's advisers lobbied the index providers to shorten that gap. Nasdaq said yes: from May 2026, a top-40 company can join the Nasdaq-100 after just 15 trading days, with the old 10% minimum float requirement removed entirely. FTSE Russell said yes faster — five trading days. S&P said no, keeping its rule requiring a year of listing and actual GAAP profits, stating that exceptions "should not be granted solely based on market capitalization."

That refusal spared S&P 500 fund holders roughly $14 billion of forced buying — for now. But if you hold a Nasdaq-100 fund, a Russell fund, or a total-market fund, you are buying SpaceX within weeks of listing, automatically, at whatever the price happens to be. Nobody will ask you.

Who benefits from the excitement

Before weighing the decision, weigh the information environment. Almost everyone amplifying this story has a stake in you believing it. The listing company gets a validated-looking valuation, a permanent base of price-insensitive index buyers, and cheaper capital for whatever it raises next — that's why its advisers spent the spring lobbying index providers rather than persuading fund managers. The banks earn underwriting fees on the largest float in history. Half a dozen new space-and-AI themed funds have launched in months to catch the flows. And a 30% retail allocation only works if retail believes.

None of this means the company is bad, or that anyone is lying. It means the loudest voices are not neutral, and the excitement you're feeling has been professionally manufactured to be felt. When everyone telling you the story is paid by the story, your scepticism is the only unconflicted opinion in the room.

Mistake 1: confusing valuation with validation

A trillion-dollar valuation feels like proof of quality. It isn't — it's just what the last buyer paid. It says nothing about whether the price is justified. The loudest signal around a hyped IPO is the number everyone quotes, and it's the one that tells you the least.

Mistake 2: confusing the company with the price

A company can be everything its believers say — dominant, world-changing — and still be a poor investment from a high enough starting price, because that price already assumes most of the future happens. Investors who correctly believed in 1999 that the internet would eat the world, and bought the leading network-equipment stock to express it, waited over two decades to get their money back. Right thesis, wrong price. The question is never "is this a great company?" — at twice oversubscribed, the market loudly agrees. The question is "do I believe something the price doesn't already contain?" That's a much higher bar.

Mistake 3: thinking you've spotted the trade

The mechanics look like a free option: buy at the IPO, sell into the wall of forced index-fund buying a few weeks later. The buyer is guaranteed and the date is roughly known. But when a trade is this well-telegraphed — public rule changes, a known inclusion timetable, twice-oversubscribed demand — the edge is already in the price. You'd be competing with professionals to sell into the same demand, with worse execution and no hedge. By the time a trade is legible to retail, the cheap part has usually been taken.

Mistake 4: forgetting you already own it

If SpaceX performs, your tracker funds will accumulate it automatically and your exposure grows with its index weight. You don't need to act to participate — that is literally what indexing does. The reverse is also true: passive investing means owning things you don't believe in alongside things you do. Your conviction can be expressed in a deliberately small, named satellite position; your scepticism gets diluted to irrelevance in the index. Neither opinion can sink you — unless you size it like it can't be wrong.

"But I'm into AI, and this looks exciting"

Then you might be right about the world. That's not the trap. The trap is letting a belief about technology answer a question about price. "AI will change everything" and "this stock at this valuation will reward me" are two different bets, and only the second one pays you. History's most expensive investing mistakes weren't made by people who were wrong about the future — they were made by people who were right about it and paid a price that assumed it twice over.

Excitement also has a tell: urgency. If the pull is "I need to get in now, at the most-anticipated listing in history, before it runs" — that isn't early. Early was a decade ago, in the private rounds you weren't offered. What's being offered to you now is the front of the public queue, at full price, with the institutions selling into your enthusiasm. A genuine decade-long conviction position doesn't care what the chart does in July.

The honest framework for any hyped listing

1. Ask who's telling you the story. If every voice amplifying the opportunity profits from your participation, discount accordingly.
2. Check what you already hold. Your funds may be enrolling you regardless — concentration can arrive without a single decision from you.
3. Separate the two beliefs. Believing in the technology and believing in the price are different bets. Only the second one pays.
4. Name the position honestly. A small conviction holding you'll keep for a decade is coherent. Chasing the most-anticipated listing in history because it feels urgent is the hype doing exactly what it was built to do.
5. Size it so being wrong doesn't matter. With a hyped, low-float, unprofitable stock, the price in the first weeks is likely the most distorted it will ever be — in both directions.

Key takeaway: Hype doesn't usually cost investors money by being wrong about the technology. It costs them money by making the price feel urgent, the sizing feel safe, the sellers feel neutral — and the exposure they already have feel invisible.

Arken maps your true exposure across every holding — including what your index funds hold inside them — so a hyped new entrant shows up in your concentration picture the moment it shows up in your portfolio.